Demetrius Matassov

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Immune correlates of postexposure vaccine protection against Marburg virus”.

Immune correlates of postexposure vaccine protection against Marburg virus

Scientific Reports(2020)10.1038/s41598-020-59976-3

N/A

0DataRank · unranked

33 citations

Allen Jankeel, Demetrius Matassov, Joan B. Geisbert, Krystle N. Agans, Viktoriya Borisevich +10 more

An introduction to the Marburg virus vaccine consortium, MARVAC

PLoS Pathogens(2022)10.1371/journal.ppat.1010805

N/A

0DataRank · unranked

54 citations

Ira M. Longini, Stephan Becker, Karin Bok, David Boucher, Miles W. Carroll +40 more

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

PLoS neglected tropical diseases(2022)10.1371/journal.pntd.0010433

N/A

0DataRank · unranked

44 citations

Robert W. Cross, Krystle N. Agans, Viktoriya Borisevich, Daniel J. Deer, Joan B. Geisbert +8 more

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.22.477345

N/A

0DataRank · unranked

6 citations

Robert W. Cross, Krystle N. Agans, Viktoriya Borisevich, Daniel J. Deer, Joan B. Geisbert +8 more

A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad157

N/A

0DataRank · unranked

21 citations

Viktoriya Borisevich, Krystle N. Agans, Rachel Sarah O’Toole, Karla A. Fenton, Mack B. Harrison +9 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever

Vaccine(2025)10.1016/j.vaccine.2025.127137

N/A

0DataRank · unranked

0 citations

Melissa Wynn, L. J. Charles, Stefan Hamm, Demetrius Matassov, Cheryl Gerardi +4 more